TABLE 2.
Outcome | Variable | Multivariate analysis | |
---|---|---|---|
OR (CI) | P value | ||
Mortality | Age | 2.4 (1.4–4.1) | <0.001* |
Heart disease | 1.5 (0.9–2.6) | 0.124 | |
Immune compromised | 2 (0.9–4.3) | 0.100 | |
Chronic lung disease | 1.8 (0.9–3.7) | 0.098 | |
Chronic kidney disease | 2.4 (1.1–5.2) | 0.020* | |
Influenza B | 1.1 (0.3–3.7) | 0.908 | |
H1N1 | 1.9 (0.8–4.5) | 0.136 | |
Influenza A | 0.5 (0.1–1.6) | 0.237 | |
Respiratory syncytial virus | 1.5 (0.5–4.5) | 0.492 | |
ICU admission | Antiviral medication | 2.5 (1.6–3.9) | <0.001* |
Influenza A | 1.7 (0.9–3.2) | 0.074 | |
Heart disease | 1.5 (1–2.3) | 0.035* | |
Chronic hematological disorder | 5.9 (3.1–11.1) | <0.001* | |
Chronic lung disease | 2.7 (1.6–4.6) | <0.001* | |
Chronic kidney disease | 2.2 (1.2–4.2) | 0.016* | |
Influenza B | 1.3 (0.6–3.1) | 0.483 | |
H1N1 | 1.3 (0.7–2.4) | 0.492 | |
Respiratory syncytial virus | 1.6 (0.8–3.4) | 0.194 | |
Mechanical ventilation | Age | 1.2 (0.7–1.8) | 0.510 |
Antiviral medication | 2.3 (1.3–3.9) | <0.001* | |
Influenza A | 1.2 (0.7–2.2) | 0.520 | |
Respiratory syncytial virus | 2.5 (1.1–5.5) | 0.02* | |
Chronic lung disease | 3.1 (1.7–5.5) | <0.001* | |
Chronic kidney disease | 2.1 (1–4.4) | 0.05* | |
Heart disease | 1.5 (0.9–2.5) | 0.120 |
Significant association at the 0.05 level (2‐tailed).